Close

We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience.

By continuing to use our website without changing the settings, you are agreeing to our use of cookies.

Find out more

Willow bark trials for osteoarthritis

Two RCTs were found examining the effectiveness of willow bark in treating hip and knee osteoarthritis. Willow bark was well-tolerated by participants who received it in both RCTs. Lack of effectiveness was the most common reason for withdrawal.

Trial 1

In the first trial, 127 participants were randomised to receive willow bark (240 mg of salicin), 100 mg diclofenac (a non-steroidal anti-inflammatory drug) or a placebo once a day for six weeks.

  • Participants who were on diclofenac had the best levels of pain relief.
  • Those assigned willow bark didn’t significantly differ from the placebo group.

Trial 2

In the second trial, 78 participants were randomly assigned to either willow bark (240 mg of salicin) or placebo tablets once a day for two weeks. Participants taking willow bark achieved a 14% reduction in pain, compared to only 2% in the placebo group.

Helpline

0800 5200 520

Our new helpline: Call us for free information, help and advice on your type of arthritis.

All calls are recorded for training and quality purposes

More Information Close
For more information, go to www.arthritisresearchuk.org.
Arthritis Research UK fund research into the cause, treatment and cure of arthritis. You can support Arthritis Research UK by volunteering, donating or visiting our shops.